SCHEMBL18995286

SCHEMBL18995286

COC1CCNC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15893898 1.00
SCHEMBL19338318 1.00
SCHEMBL8778452 0.88 OR51E2 (0.38)
SCHEMBL8299348 0.81 CRBN (0.40)
SCHEMBL22253150 0.79 TSHR (0.36)
SCHEMBL22253147 0.78
SCHEMBL20667261 0.78 MAP2K1 (0.30)
SCHEMBL5986534 0.78 CYP1A2 (0.31)
SCHEMBL22255180 0.78 MAP2K1 (0.30)
SCHEMBL5759844 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116934-A1 KRASG12D PROTEIN HYDROLYSIS REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州泽璟生物制药股份有限公司 2023-06-29 WO disclosed
US-20210292285-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC (US) 2021-09-23 US disclosed
WO-2020150674-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC. (US) 2020-07-23 WO disclosed
EP-2947085-B1 OXAZOLIDONE COMPOUNDS, METHOD FOR PREPARING AND APPLICATION THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2017-09-13 EP disclosed
US-9682968-B2 Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof NOVARTIS AG (CH) 2017-06-20 US disclosed